Cargando…
Contrast Enhanced MRI in the Diagnosis of HCC
Hepatocellular carcinoma (HCC) is the 6th most common cancer worldwide. Imaging plays a critical role in HCC screening and diagnosis. Initial screening of patients at risk for HCC is performed with ultrasound. Confirmation of HCC can then be obtained by Computed Tomography (CT) or Magnetic Resonance...
Autores principales: | Niendorf, Eric, Spilseth, Benjamin, Wang, Xiao, Taylor, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665604/ https://www.ncbi.nlm.nih.gov/pubmed/26854161 http://dx.doi.org/10.3390/diagnostics5030383 |
Ejemplares similares
-
Measurement of Prostate Volume with MRI (A Guide for the Perplexed): Biproximate Method with Analysis of Precision and Accuracy
por: Wasserman, Neil F., et al.
Publicado: (2020) -
HCC screening: assessment of an abbreviated non-contrast MRI protocol
por: Chan, Michael Vinchill, et al.
Publicado: (2019) -
Diagnosis of Pathologically Early HCC with EOB-MRI: Experiences and Current Consensus
por: Ichikawa, Tomoaki, et al.
Publicado: (2014) -
Application of Dynamic Contrast-Enhanced MRI in the Diagnosis of Rheumatoid Arthritis
por: Zhang, Bin, et al.
Publicado: (2022) -
Comparison of LI-RADS v.2017 and ESGAR Guidelines Imaging Criteria in HCC Diagnosis Using MRI with Hepatobiliary Contrast Agents
por: Rosiak, Grzegorz, et al.
Publicado: (2018)